Improving lung cancer surgery with a new diagnostic tool
Official title: Validation and Translation of MasSpec Pen Technology for Intraoperative Evaluation of Non-small Cell Lung Cancer
Funded at Baylor College of Medicine · NIH-11093913 · Data updated 2026-11-12
This study is testing a new tool called the MasSpec Pen that helps doctors quickly and accurately identify cancerous tissues during surgery for non-small cell lung cancer, aiming to make surgeries safer and more effective for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | June 2, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $603,561 |
| NIH project number | 5R01CA284742-03 |
| Project ID | NIH-11093913 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with non-small cell lung cancer who are scheduled for surgical intervention.
✕Less likely to help
Patients with other types of lung cancer or those not requiring surgical treatment may not benefit from this research.
What this research studies
This research focuses on enhancing the surgical treatment of non-small cell lung cancer (NSCLC) by validating a new technology called the MasSpec Pen. This innovative tool allows for rapid and accurate diagnosis of cancerous tissues during surgery, which is crucial for determining the extent of tumor removal. By providing real-time feedback to surgeons, the MasSpec Pen aims to reduce the reliance on outdated methods that can lead to errors and longer surgery times. Patients undergoing surgery for NSCLC may benefit from improved outcomes and reduced complications due to more precise surgical decisions.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective surgical treatments for lung cancer patients.
How similar studies have gone: Previous research has shown promise in using innovative diagnostic technologies in surgical settings, suggesting potential success for the MasSpec Pen.
Where this research is happening
-
Baylor College of Medicine
Houston, United States Active
Researchers
- Principal investigator: Schiavinato Eberlin, Livia — Baylor College of Medicine
- Study coordinator: Schiavinato Eberlin, Livia
Related research
Other NIH-funded projects on the same topics.
-
ABL kinase signaling and DNA collisions in small cell lung cancer
A drug target study in small cell lung cancer explores how blocking ABL kinase affects conflicts between transcription and DNA replication, which could influence tumor growth and survival.
-
XRN1 as a potential therapy target in lung cancer
A scientist-led program will study a cellular gene called XRN1 to see if turning it off can help treat non-small cell lung cancer.
-
Intermittent fasting with PD-1 inhibitors for non-small cell lung cancer
This grant tests whether a fasting-mimicking diet can boost the effectiveness of PD-1 inhibitors for people with non-small cell lung cancer.
-
Targeting STRAP to curb NSCLC spread with nanoparticle therapy
Aimed at non-small cell lung cancer, this grant tests how blocking a protein called STRAP with nanoparticles could slow cancer spread and make chemotherapy work better.
-
Modeling tumor differences to guide new treatments for resistant small cell lung cancer
A study aims to understand why some small cell lung cancer tumors resist treatment and use those insights to develop new targeted therapies.
-
TP53-mutant NSCLC: how epigenetic viral mimicry could boost immune therapy
A research grant exploring how p53 mutations in non-small cell lung cancer affect responses to a viral mimicry-based epigenetic therapy, with the goal of improving immune therapy outcomes for patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.